Beyond the Label: Ensuring That Drug Benefits Outweigh Risks in the Food and Drug Administration's Risk Evaluation and Mitigation Strategy Program

Michael S. Epstein, Eric D. Shah, Parakkal Deepak, Vladimir M. Kushnir

Research output: Contribution to journalComment/debate

1 Scopus citations
Original languageEnglish
Pages (from-to)1017-1019
Number of pages3
JournalAmerican Journal of Gastroenterology
Issue number7
StatePublished - Jul 2019

Cite this